Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships
04:51pm, Monday, 21'st Jun 2021
Some say INO stock could be the target of a short squeeze, but Inovio's Covid-19 vaccine program should be a sufficient reason to invest. The post Inovio Pharmaceuticals Could See a Boost from Covid-1
Should You Buy Biotech ETFs Now?
01:32pm, Wednesday, 16'th Jun 2021
Biotech stocks are rallying this month; can the trend continue?
Why Inovio Stock Is Sinking Today
11:46am, Thursday, 10'th Jun 2021
Investors appear to be taking some profits after yesterday's huge gain.
Why Inovio Stock Looks Ready To Break Out, Make Bullish Reversal
02:50pm, Wednesday, 09'th Jun 2021
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares were trading higher Wednesday as retail traders continue to push high short interest stocks higher. The stock saw above average volume and was trending
INO Stock: 2 Big Reasons Inovio Pharmaceuticals Is Shooting Higher Today
02:40pm, Wednesday, 09'th Jun 2021
Today, INO stock is soaring amid a recently announced expanded partnership for its Covid-19 vaccine and potential short squeeze implications. The post INO Stock: 2 Big Reasons Inovio Pharmaceuticals I
Inovio, Advaccine to Share $100M in Cost for Late-Stage COVID-19 Vaccine Trial
10:34am, Tuesday, 08'th Jun 2021
Inovio Pharmaceuticals Inc (NASDAQ: INO) has expanded its partnership with Advaccine Biopharmaceuticals Suzhou Co Ltd to jointly conduct a global Phase 3 part of the ongoing Phase 2/3 trial, INN
INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate, INO-4800
08:00am, Tuesday, 08'th Jun 2021
PLYMOUTH MEETING, Pa., June 8, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infect
These Vaccine Latecomers Could Still Win Big. Here's How
03:13pm, Monday, 07'th Jun 2021
The key is standing out from the crowd.
Why Inovio Pharmaceuticals Stock Perked Up in May
01:15pm, Sunday, 06'th Jun 2021
The biotech's pan-COVID-19 vaccine caught the eye of investors last month.
Geneos Therapeutics Announces Clinical Updates on Personalized Cancer Vaccine Program
08:00am, Thursday, 03'rd Jun 2021
PLYMOUTH MEETING, Pa., June 3, 2021 /PRNewswire/ -- Geneos Therapeutics, a clinical stage company focused on the development of tumor neoantigen targeted personalized immunotherapies for cancer, anno
Is It Too Late to Buy Inovio Pharmaceuticals Stock?
06:55am, Thursday, 03'rd Jun 2021
This troubled coronavirus vaccine developer has created far more woes than joys for investors.
INOVIO Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at Jefferies 2021 Virtual Healthcare Conference (Transcript)
05:15pm, Tuesday, 01'st Jun 2021
INOVIO Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at Jefferies 2021 Virtual Healthcare Conference (Transcript)
New to Investing? 3 Beginner Mistakes to Avoid
09:22am, Tuesday, 01'st Jun 2021
There are plenty of things you'll learn through your experiences as an investor, but these are ones to learn as soon as possible.
7 Former Pandemic Stocks to Buy That Are No Longer Running Hot
10:07am, Wednesday, 26'th May 2021
The pandemic bolstered many stocks to buy. But with cases fading, this narrative is now questionable.
INOVIO to Present at the Jefferies 2021 Virtual Healthcare Conference
08:00am, Tuesday, 25'th May 2021
PLYMOUTH MEETING, Pa., May 25, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO) a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infecti
